Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins? (Q34796627)

4 August 2017

Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins? (English)

1 reference

p-tolyl-beta-D-glucuronide

4 August 2017

1 reference

ChEBI release 2020-05-28

8

Raymond Vanholder

1 reference

4 August 2017

Sophie Liabeuf

1

1 reference

4 August 2017

Griet Glorieux

2

1 reference

4 August 2017

Aurelie Lenglet

3

1 reference

4 August 2017

Momar Diouf

4

1 reference

4 August 2017

Eva Schepers

5

1 reference

4 August 2017

Lucie Desjardins

6

1 reference

4 August 2017

Gabriel Choukroun

7

1 reference

4 August 2017

Ziad A Massy

9

1 reference

4 August 2017

European Uremic Toxin (EUTox) Work Group

10

1 reference

4 August 2017

language of work or name

English

0 references

publication date

24 June 2013

1 reference

4 August 2017

1 reference

4 August 2017

8

1 reference

4 August 2017

6

1 reference

4 August 2017

e67168

1 reference

Creative Commons Attribution 4.0 International

4 August 2017

start time

24 June 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

Protein-bound uremic toxins: new insight from clinical studies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

Vascular incompetence in dialysis patients--protein-bound uremic toxins and endothelial dysfunction.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

p-Cresol and cardiovascular risk in mild-to-moderate kidney disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

The role of oxidative stress in chronic kidney disease.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

The uremic retention solute p-cresyl sulfate and markers of endothelial damage.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

What is new in uremic toxicity?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

A bench to bedside view of uremic toxins

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

Pathophysiologic effects of uremic retention solutes.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

Uremic toxicity: the middle molecule hypothesis revisited.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

Binding of p-cresylsulfate and p-cresol to human serum albumin studied by microcalorimetry

8 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0067168

Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0067168

Oral ADSORBENT AST-120 decreases carotid intima-media thickness and arterial stiffness in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0067168

Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0067168

Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

Free p-cresol is associated with cardiovascular disease in hemodialysis patients

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

Toxicity of free p-cresol: a prospective and cross-sectional analysis

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

P-cresol, a uremic toxin, decreases endothelial cell response to inflammatory cytokines

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691113

Pulse wave velocity and vascular calcification at different stages of chronic kidney disease

26 October 2018

1 reference

12 December 2020

Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production

1 reference

12 December 2020

Carotid plaques, but not common carotid intima-media thickness, are independently associated with aortic stiffness

1 reference

12 December 2020

Study of the intestinal tyrosine metabolism using stable isotopes and gas chromatography-mass spectrometry

1 reference

12 December 2020

New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study

1 reference

12 December 2020

A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0067168

Identifiers

DOI

1 reference

4 August 2017

0 references

1 reference

4 August 2017

1 reference